{"transactions":[{"id":4634179,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-03T00:54:34.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":9.408,"value":141120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.180 to $9.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1599208,"source":{"system":"sec-edgar","filing":"0001867096-26-000085","document":"wk-form4_1790974469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000085/wk-form4_1790974469.xml","form_type":"4"}},{"id":4628400,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-29T20:59:34.000Z","date":"2026-09-28","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."}],"balance_after":1614208,"source":{"system":"sec-edgar","filing":"0001867096-26-000078","document":"wk-form4_1790715570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000078/wk-form4_1790715570.xml","form_type":"4"}},{"id":671416,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-01T22:21:17.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":8.4872,"value":127308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.390 to $8.600, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1639208,"source":{"system":"sec-edgar","filing":"0002031695-26-000011","document":"wk-form4_1788301275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000011/wk-form4_1788301275.xml","form_type":"4"}},{"id":679085,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-21T20:15:33.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":21918,"price":8.08,"value":177097.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2026."}],"balance_after":1654208,"source":{"system":"sec-edgar","filing":"0001867096-26-000069","document":"wk-form4_1787343331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000069/wk-form4_1787343331.xml","form_type":"4"}},{"id":697534,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-04T21:30:27.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":8.016,"value":120240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.000 to $8.150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1676126,"source":{"system":"sec-edgar","filing":"0001867096-26-000059","document":"wk-form4_1785879024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000059/wk-form4_1785879024.xml","form_type":"4"}},{"id":718623,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-02T20:40:55.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":90000,"price":8.0279,"value":722511.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as of September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.000 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,401 shares acquired on June 30, 2026 under the issuer's 2018 Employee Stock Purchase Plan, as amended."}],"balance_after":1691126,"source":{"system":"sec-edgar","filing":"0002031695-26-000008","document":"wk-form4_1783024852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000008/wk-form4_1783024852.xml","form_type":"4"}},{"id":842024,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":4,"price":3.94,"value":15.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received the stock options on August 26, 2020 pursuant to an award under the 2018 Plan. 50% of the options vested on the first anniversary of the vesting commencement date, 25% of the options vested on the 18-month anniversary of the vesting commencement date, and the remaining 25% of options vested on the two-year anniversary of the vesting commencement date, in each case subject to continued employment through such vesting date."}],"balance_after":79996,"derivative":{"exercise_price":3.94,"expiration_date":"2030-08-26","underlying":"Common Stock","underlying_shares":4},"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":842023,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":48894,"price":4.09,"value":199976.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received the stock options on December 10, 2020 pursuant to an award under the Company's 2018 Stock Option/Stock Issuance Plan (the \"2018 Plan\"). 50% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 50% of options vested on the second anniversary of the vesting commencement date, in each case subject to continued employment\nthrough such vesting date."}],"balance_after":43773,"derivative":{"exercise_price":4.09,"expiration_date":"2027-12-10","underlying":"Common Stock","underlying_shares":48894},"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":842022,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":4,"price":3.94,"value":15.76,"ownership":{"direct":true},"balance_after":1777725,"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":842021,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":48894,"price":4.09,"value":199976.46,"ownership":{"direct":true},"balance_after":1777721,"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":925548,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":225225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date."}],"balance_after":225225,"derivative":{"exercise_price":7.36,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":225225},"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925547,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":27319,"price":7.36,"value":201067.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1727827,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925546,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":30289,"price":7.36,"value":222927.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1755146,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925545,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":68454,"price":7.36,"value":503821.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1785435,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925544,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":168463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date."}],"balance_after":1853889,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":942449,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-09T22:34:56.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":8,"value":120000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1685426,"source":{"system":"sec-edgar","filing":"0002031695-26-000002","document":"wk-form4_1767998094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000002/wk-form4_1767998094.xml","form_type":"4"}},{"id":1024959,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:21:11.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":733,"price":8.31,"value":6091.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of October 2, 2025."}],"balance_after":1700426,"source":{"system":"sec-edgar","filing":"0002031695-25-000006","document":"wk-form4_1759526468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169525000006/wk-form4_1759526468.xml","form_type":"4"}},{"id":1040703,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-15T21:33:15.000Z","date":"2025-09-11","kind":"other","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Charles R. McCulloch Trust dated 1990"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is trustee of the Charles R. McCulloch Trust, of which he is a beneficiary. On September 11, 2025, the reporting person caused the trust to distribute 2,000 shares of the Issuer's common stock to a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.  No sale of shares occurred in the transfer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002031695-25-000004","document":"wk-form4_1757971992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169525000004/wk-form4_1757971992.xml","form_type":"4"}},{"id":1076482,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-04T20:24:34.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":14651,"price":5.38,"value":78822.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":1701159,"source":{"system":"sec-edgar","filing":"0001867096-25-000123","document":"wk-form4_1754339070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000123/wk-form4_1754339070.xml","form_type":"4"}},{"id":1110079,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-16T20:26:02.000Z","date":"2025-06-13","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":4.379,"value":109475.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.3750 to $4.380, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":1708585,"source":{"system":"sec-edgar","filing":"0001867096-25-000118","document":"wk-form4_1750105556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000118/wk-form4_1750105556.xml","form_type":"4"}},{"id":1180303,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-03T20:20:05.000Z","date":"2025-04-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":733,"price":5.15,"value":3774.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of April 2, 2025."}],"balance_after":1683585,"source":{"system":"sec-edgar","filing":"0001867096-25-000060","document":"wk-form4_1743711598.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000060/wk-form4_1743711598.xml","form_type":"4"}},{"id":1287632,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2025-02-04T00:40:39.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock appreciation right granted under the Company's 2018 Stock Option and Incentive Plan will vest in full on the second anniversary of the January 31, 2025 grant date, subject to continued service with the company through the vesting date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F5","text":"Upon exercise, the stock appreciation right will be settled in cash."}],"balance_after":500000,"derivative":{"exercise_price":3.56,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001867096-25-000027","document":"wk-form4_1738629632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000027/wk-form4_1738629632.xml","form_type":"4"}},{"id":1287631,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T00:40:39.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years."}],"balance_after":1684318,"source":{"system":"sec-edgar","filing":"0001867096-25-000027","document":"wk-form4_1738629632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000027/wk-form4_1738629632.xml","form_type":"4"}},{"id":1287630,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T00:40:39.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":48834,"price":3.56,"value":173849.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2025."}],"balance_after":1499318,"source":{"system":"sec-edgar","filing":"0001867096-25-000027","document":"wk-form4_1738629632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000027/wk-form4_1738629632.xml","form_type":"4"}},{"id":1287629,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T00:40:39.000Z","date":"2025-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":29300,"price":3.56,"value":104308.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2025."}],"balance_after":1548152,"source":{"system":"sec-edgar","filing":"0001867096-25-000027","document":"wk-form4_1738629632.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000027/wk-form4_1738629632.xml","form_type":"4"}},{"id":1308445,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-07T21:42:59.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":24501,"price":3.61,"value":88448.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of Restricted Stock Units vested as of January 3, 2025."}],"balance_after":1577452,"source":{"system":"sec-edgar","filing":"0001867096-25-000014","document":"wk-form4_1736286172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000014/wk-form4_1736286172.xml","form_type":"4"}},{"id":1443191,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Appreciation Right","published_at":"2024-08-02T21:22:39.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The award will vest in full on the two-year anniversary of the grant date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Upon exercise, the Stock Appreciation Right will be settled in cash."}],"balance_after":200000,"derivative":{"exercise_price":2.43,"expiration_date":"2026-09-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001867096-24-000144","document":"wk-form4_1722633751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709624000144/wk-form4_1722633751.xml","form_type":"4"}},{"id":1443190,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-08-02T21:22:39.000Z","date":"2024-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1601953,"source":{"system":"sec-edgar","filing":"0001867096-24-000144","document":"wk-form4_1722633751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709624000144/wk-form4_1722633751.xml","form_type":"4"}}]}